» Articles » PMID: 28980458

Application of a Novel Prognostic Invasive Lesion Index in Ductal Carcinoma in Situ with Minimal Invasion of the Breast

Overview
Journal Cancer Med
Specialty Oncology
Date 2017 Oct 6
PMID 28980458
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple invasive foci has been shown to increase the risk of lymph node metastasis (LNM) in early breast cancer, but its prognostic implication remains unknown. We aimed to identify the prognostic value of the number of invasive foci in ductal carcinoma in situ with minimal invasion of the breast (DCIS-MI), and further establish a prognostic invasive lesion index (ILI). A total of 193 patients with DCIS-MI (the invasive component was up to 10 mm in diameter) were included. Univariate and multivariate analysis (logistic regression) were used to evaluate the predictive value of the number of invasive foci in LNM. The Kaplan-Meier curve was used for survival analysis. More than five invasive foci was an independent predictor for LNM (OR, 2.67, 95% CI, 1.12-6.33, P = 0.026), and associated with significantly shorter disease-free survival (DFS) and overall survival (OS) compared with no more than five invasive foci (mean DFS 123.8 vs. 148.0 months, P = 0.002; and mean OS 133.5 vs. 151.4 months, P = 0.025). The ILI was established by the sum scores of the number of invasive foci and the invasive component size, having an optimal cut-off point of 5.5 scores. The high-ILI group (ILI >5 scores) had a higher incidence of LNM (23.6% vs. 6.9%) and worse prognosis than the low-ILI group (ILI ≤5 scores). In conclusion, more than five invasive foci was an independent predictor for LNM and an unfavorable prognostic parameter. The ILI could potentially be used to predict survival prognosis in patients with DCIS-MI.

Citing Articles

Survival outcomes after breast-conserving surgery plus radiotherapy compared with mastectomy in breast ductal carcinoma in situ with microinvasion.

Xia L, Xu W, Hu Q Sci Rep. 2022; 12(1):20132.

PMID: 36418384 PMC: 9684534. DOI: 10.1038/s41598-022-24630-7.


Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast.

He X, Ye F, Li M, Yu P, Xiao X, Tang H Cancer Med. 2017; 6(11):2489-2496.

PMID: 28980458 PMC: 5673919. DOI: 10.1002/cam4.1175.

References
1.
Carter C, Allen C, Henson D . Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989; 63(1):181-7. DOI: 10.1002/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h. View

2.
Bevilacqua J, Kattan M, Fey J, Cody 3rd H, Borgen P, Van Zee K . Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol. 2007; 25(24):3670-9. DOI: 10.1200/JCO.2006.08.8013. View

3.
Silverberg S, Chitale A . Assessment of significance of proportions of intraductal and infiltrating tumor growth in ductal carcinoma of the breast. Cancer. 1973; 32(4):830-7. DOI: 10.1002/1097-0142(197310)32:4<830::aid-cncr2820320413>3.0.co;2-p. View

4.
Giuliano A, Connolly J, Edge S, Mittendorf E, Rugo H, Solin L . Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017; 67(4):290-303. DOI: 10.3322/caac.21393. View

5.
Maibenco D, Weiss L, Pawlish K, Severson R . Axillary lymph node metastases associated with small invasive breast carcinomas. Cancer. 1999; 85(7):1530-6. View